Dxcover Limited, a clinical stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, announced the launch of the Dxcover® platform, a ground-breaking platform that transforms Attenuated Total Reflectance Fourier Transform Infrared spectroscopy to enable faster sample analysis.
June 20, 2022
· 2 min read